Research Article
Experience and Expectations of Ovarian Cancer Patients in Australia
Table 1
Participant demographics.
| Demographic | | % |
| Age | | | 35 to 44 | 5 | 12.5% | 45 to 54 | 10 | 25.0% | 55 to 64 | 10 | 25.0% | 65 to 74 | 12 | 30.0% | 75 or older | 3 | 7.5% | Geographic location within Australia | | | NSW | 15 | 37.5% | VIC | 12 | 30.0% | QLD | 7 | 17.5% | WA | 6 | 15.0% | Level of education | | | Less than high school degree | 1 | 2.5% | High school degree or equivalent | 5 | 12.5% | Some university but no degree | 12 | 30.0% | Bachelor degree | 11 | 27.5% | Associate degree | 5 | 12.5% | Graduate degree | 6 | 15.0% | Year of diagnosis | | | 2008 | 2 | 5.0% | 2009 | 1 | 2.5% | 2010 | 4 | 10.0% | 2011 | 1 | 2.5% | 2012 | 12 | 30.0% | 2013 | 13 | 32.5% | 2014 | 7 | 17.5% | Primary tumour site | | | Ovary | 31 | 77.5% | Fallopian tube | 8 | 20.0% | Peritoneum | 1 | 2.5% | Histology | | | Epithelial | 34 | 85.0% | (i) Serous: high grade | 21 | 52.5% | (ii) Serous: low grade | 3 | 7.5% | (iii) Clear cell | 3 | 7.5% | (iv) Endometrioid | 3 | 7.5% | (v) N/A or unknown | 4 | 10.0% | Sex cord stromal | 1 | 2.5% | Unknown | 5 | 12.5% | BRCA status | | | Negative | 20 | 50.5% | Positive | 7 | 17.5% | Unknown | 13 | 32.5% | Lines of chemotherapy completed | | | 0 | 1 | 2.5% | 1 | 20 | 50.0% | 2 | 12 | 30.0% | 3 | 5 | 12.5% | 4 | 1 | 2.5% | 5 | 1 | 2.5% | Current treatment status | | | Maintenance therapy after primary treatment | 3 | 7.5% | Surveillance after primary treatment | 16 | 40.0% | Maintenance therapy postrecurrence | 5 | 12.5% | Surveillance postrecurrence | 4 | 10.0% | Recurrence, with no treatment | 2 | 5.0% | Recurrence, with treatment | 9 | 22.5% | Palliative | 1 | 2.5% |
|
|